Characteristic | Total (%) (n = 508) |
---|---|
Age, years (median [IQR]) | 53.9 (46.8–59.3) |
Black race | 441 (86.8) |
Male sex | 345 (67.9) |
Female sex | 163 (32.1) |
High school education or higher | 202 (39.8) |
Homelessnessa | 98 (19.3) |
Incarcerated ≥1 weeka | 51 (10.1) |
HCV Genotype | |
 1a | 421 (82.9) |
 1b | 87 (17.1) |
HIV positive at baseline | 167 (32.9) |
HIV seroconverted (baseline to most recent visit) | 29 (5.7) |
HIV positive at most recent visit | 196 (38.6) |
Most recent HIV RNA among HIV infectedb | |
 HIV RNA < 400 copies/ml | 111 (56.6) |
 HIV RNA ≥ 400 copies/ml | 51 (26.0) |
Prescribed methadone or buprenorphine | 176 (34.7) |
Injection drug use behaviors | |
 Years injecting (mean [SD]) | 12.68 (10.8) |
 Ever shared a syringe at baseline | 451 (89.1) |
 Injected drugsa | 204 (40.2) |
 Shared syringea | 85 (16.7) |
 Used cracka | 157 (31.0) |
 Injected or snorted cocainea | 112 (22.1) |
 Injected heroina | 146 (28.7) |
 Snorted heroina | 85 (16.7) |
 Injected speedballa | 122 (24.0) |
 Visited SSP in the last month | 61 (12.1) |